About
Dr. Charlene Waryah is a Postdoctoral Research Fellow affiliated with The University of Western Australia (UWA), based at the Harry Perkins Institute of Medical Research. She holds positions in the School of Human Sciences, Australian Centre for RNA Therapeutics in Cancer, UWA Medical School, and UWA Centre for Medical Research. Her research focuses on CRISPR-based epigenetic editing and the development of molecular therapeutics targeting dysregulated cancer cells.
Her work contributes to UN Sustainable Development Goals related to health and well-being. Key collaborations include projects on triple-negative breast cancer and hepatocellular carcinoma. Dr. Waryah leads CRISPR epigenetic editing projects in the Cancer Epigenetics laboratory under Prof. Pilar Blancafort. She has secured grants from NHMRC and Cancer Australia, including a current project on epigenome engineering for breast cancer therapy.
Research interests include tumor suppressor gene reactivation, epigenetic reprogramming, and CRISPR technologies. She has contributed to over 14 peer-reviewed publications and 12 datasets, with notable citations in journals like Advanced Science and Nature Communications.
Find Charlene Waryah elsewhere
Related Searches
You Might Also Like
Pilar BlancafortThe University of Western Australia · Associate Professor- EEdina WangThe University of Western Australia · Researcher
Emily GoldenThe University of Western Australia · Research Fellow
Andrew RedfernThe University of Western Australia · Associate Professor- KKavish Hasnain KhinsarThe University of Western Australia · Researcher
- TTrung Viet NguyenThe University of Western Australia · Researcher